RCM
ARKG icon

Richardson Capital Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Richardson Capital Management’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-739
Closed -$18K – 226
2025
Q2 		$18K Hold
739
– – 0.01% 119
2025
Q1 		$15.3K Hold
739
– – 0.01% 126
2024
Q4 		$17.4K Buy
+739
New +$18.2K 0.01% 103
2024
Q3 		– Sell
-739
Closed -$17.4K – 144
2024
Q2 		$17.4K Hold
739
– – 0.01% 111
2024
Q1 		$21.3K Buy
+739
New +$22.2K 0.02% 102

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Richardson Capital Management's ARKG Position: Q3 2025 in Review

Richardson Capital Management sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2025, closing a stake of 739 shares — an estimated $18K sold.

Richardson Capital Management first reported a position in ARKG in Q1 2024 and held it in 5 quarters. The position peaked at $21.3K in Q1 2024. 231 funds tracked by Wall St. Rank hold ARKG as of Q3 2025.

  • Richardson Capital Management reported no remaining ARK Genomic Revolution ETF position as of Q3 2025 after selling out during the quarter.
  • Richardson Capital Management sold 739 ARK Genomic Revolution ETF shares in Q3 2025, an estimated $18K.
  • Richardson Capital Management first reported a position in ARK Genomic Revolution ETF in Q1 2024 and held it in 5 quarters.
  • Richardson Capital Management's ARK Genomic Revolution ETF position peaked at $21.3K in Q1 2024.
  • 231 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2025.

Based on Richardson Capital Management's 13F filing for Q3 2025, filed 31 Oct 2025.